About Hepatitis B Vaccine | Health - Hindustan Times
close_game
close_game

About Hepatitis B Vaccine

Oct 20, 2003 05:42 PM IST

Engerix ?B is a recombinant vaccine that is used to combat Hepatitis B. It has no live parts.

Engerix –B is a recombinant vaccine that is used to combat Hepatitis B. It has no live parts. It contains a portion of the outer protein of the HBV or Hepatitis B surface antigen (HBsAg).

This vaccine is administered in three doses intramuscularly. Shanvac is the other brand of Hepatitis B vaccine available in India.

HT Image
HT Image

What are the benefits of the vaccine?

Hindustan Times - your fastest source for breaking news! Read now.

Hepatitis B is a serious illness. It can lead to cirrhosis of liver or cancer of liver, even to death Therefore prevention saves a lot of trouble.

Vaccinating the child makes it safe against the disease in the adult years. A pregnant woman with infection can pass on the infection to the foetus, which will affect the newborn’s health. As vaccination is not advised during pregnancy, it is better to take the vaccination earlier.

The vaccine has been found to be safe with no serious side effects.

Who is advised the vaccine?

Since anybody can get Hepatitis B the vaccination is advised for all age groups. Though this vaccination has not been included in the Indian government’s mandatory vaccination list, paediatrician feel that this vaccination has real benefits and advise vaccination for children under their care.

People in the high risk groups are definitely advised to take these shots.

(Source: Webhealthcentre.com)

Oscars 2024: From Nominees to Red Carpet Glam! Get Exclusive Coverage on HT. Click Here

Catch your daily dose of Fashion, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On